M0243 is a valid 2023 HCPCS Code that could be used to indicate Intravenous infusion, casirivimab and imdevimab includes infusion and post administration monitoring for reimbursement purposes.
M0243 belongs to Pneumococcal/Flu Vaccine Type of Service and has been in effect since Nov 21, 2020.
Casirivi and imdevi infusion
M0243 code information
| HCPCS code: | M0243 |
| Description: | INTRAVENOUS INFUSION, CASIRIVIMAB AND IMDEVIMAB INCLUDES INFUSION AND POST ADMINISTRATION MONITORING |
| Effective Date: | Nov 21, 2020 |
| Added Date: | Nov 21, 2020 |
| Termination Date: | HCPCS M0243 was terminated on Nov 30, -0001 |
| Pricing indicator: | 54 - VACCINATIONS |
| Multi Pricing indicator: | A - NOT APPLICABLE AS HCPCS PRICED UNDER ONE METHODOLOGY |
| Coverage code: | C - CARRIER JUDGMENT |
| BETOS code: | O1G - INFLUENZA VACCINE |
| Action code: | A - ADD PROCEDURE OR MODIFIER CODE |
| Type of Service: |
V - PNEUMOCOCCAL/FLU VACCINE
|
| Anesthesia BUQ: | 0 |
Below a selection of HCPCS codes related to M0243